Xylem Reports Second Quarter 2022 Results

August 02, 2022 at 06:55 AM EDT

Robust continuing demand drove strong organic orders growth: 1% on a reported basis, 6% organically
Revenue of $1.4 billion, up 1% on a reported basis, up 6% organically
Earnings per share of $0.62, adjusted earnings per share of $0.66
Adjusted EBITDA margin exceeded guidance by 160 basis points
Raising full-year organic revenue guidance to a range of 8% to 10% from 4% to 6%, and adjusted EPS to a range of $2.50 to $2.70 from $2.40 to $2.70

Xylem Inc. (NYSE: XYL), a leading global water technology company dedicated to solving the world’s most challenging water issues, today reported second quarter revenue of $1.4 billion, surpassing previous guidance in each business segment. Strong continued global demand drove orders and backlog growth across the portfolio.

Second quarter adjusted earnings before interest, tax, depreciation and amortization (EBITDA) margin was 16.6 percent, better than the Company’s previous guidance and reflecting a year-over-year decrease of 70 basis points. Inflation and the impact of continuing chip shortages drove the margin decline, exceeding the benefits of price realization and productivity savings. Xylem generated net income of $112 million, or $0.62 per share, and adjusted net income of $120 million, or $0.66 per share, which excludes the impact of restructuring, realignment and special charges.

“The team delivered very strong second quarter performance on all key metrics, and well ahead of our guidance for the quarter,” said Patrick Decker, Xylem president and CEO. “The result reflects our commercial momentum on continuing underlying demand, disciplined operational execution, and a moderate easing in chip supply constraints.”

“On the strength of robust backlog and orders growth, and the team’s demonstrated success mitigating the effects of inflation, we are raising our full-year guidance on revenue and earnings. This further reinforces our longer-term growth and value creation thesis for Xylem.”

Outlook

Xylem now expects full-year 2022 organic revenue growth to be in the range of 8 to 10 percent, and 3 to 5 percent on a reported basis. This represents an increase from the Company’s previous full-year organic revenue guidance of 4 to 6 percent, and 1 to 3 percent on a reported basis. Full-year 2022 adjusted EBITDA margin is now expected to be in the range of 16.5 to 17.0 percent, raising the low end of the previous range of 16.0 to 17.0 percent. This results in adjusted earnings per share of $2.50 to $2.70, raising the low end from the previous range of $2.40 to $2.70. The increased guidance reflects strong demand, gradual easing of supply chain constraints and price realization partially offset by inflation and foreign exchange headwinds.

Further 2022 planning assumptions are included in Xylem’s second quarter 2022 earnings materials posted at www.xylem.com/investors. Excluding revenue, Xylem provides guidance only on a non-GAAP basis due to the inherent difficulty in forecasting certain amounts that would be included in GAAP earnings, such as discrete tax items, without unreasonable effort.

Second Quarter Segment Results

Water Infrastructure

Xylem’s Water Infrastructure segment consists of its portfolio of businesses serving clean water delivery, wastewater transport and treatment, and dewatering.

Second quarter 2022 Water Infrastructure revenue was $589 million, a 9.0 percent increase organically compared with second quarter 2021. This robust growth was driven by strong price realization, industrial dewatering demand, and healthy activity in our wastewater utility business in the U.S. and Western Europe.

Second quarter adjusted EBITDA margin was 21.4 percent, up 240 basis points from the prior year. Reported operating income for the segment was $108 million. Adjusted operating income for the segment, which excludes $3 million of restructuring and realignment, was $111 million, a 14.4 percent increase versus the comparable period last year. Reported operating margin for the segment was 18.3 percent, up 200 basis points versus the prior year, and adjusted operating margin was 18.8 percent, up 180 basis points versus the prior year. Strong price realization, volume, and productivity savings more than offset inflation and strategic investments.

Applied Water

Xylem’s Applied Water segment consists of its portfolio of businesses in industrial, commercial building, and residential applications.

Second quarter 2022 Applied Water revenue was $429 million, a 7.0 percent increase organically year-over-year. The segment delivered strong price realization and backlog execution in industrial and residential end markets, partially offset by continued supply chain constraints in commercial buildings in the United States.

Second quarter adjusted EBITDA margin was 16.1 percent, down 130 basis points from the prior year. Reported operating income for the segment was $61 million and adjusted operating income, which excludes $2 million of restructuring and realignment costs, was $63 million, a 4.5 percent decrease versus the comparable period last year. The segment reported operating margin was 14.2 percent, down 130 basis points versus the prior year period. Adjusted operating margin declined 120 basis points to 14.7 percent. Strong price realization and productivity savings were more than offset by inflation and lower volume.

Measurement & Control Solutions

Xylem’s Measurement & Control Solutions segment consists of its portfolio of businesses in smart metering, network technologies, advanced infrastructure analytics and analytic instrumentation.

Second quarter 2022 Measurement & Control Solutions revenue was $346 million, down 2.0 percent organically versus the prior year. While chip supply remains constrained, the result is better than our expectations due to improved chip supply in the quarter, and strength in our water quality test applications.

Second quarter adjusted EBITDA margin was 9.8 percent, down 410 basis points from the prior year. Reported operating income for the segment was $(5) million, and adjusted operating income, which excludes $3 million of restructuring and realignment costs and $1 million of special charges, was $(1) million, a 108 percent decrease versus the comparable period last year. The Measurement & Control Solutions segment reported operating margin was (1.4) percent, down 490 basis points versus the prior year period. Adjusted operating margin of (0.3) percent decreased 380 basis points over the prior year period. Volume declines from chip shortages, unfavorable mix and higher inflation more than offset price realization and productivity savings.

Supplemental information on Xylem’s second quarter 2022 earnings and reconciliations for certain non-GAAP items is posted at www.xylem.com/investors.

About Xylem

Xylem (XYL) is a leading global water technology company committed to solving critical water and infrastructure challenges with innovation. Our 17,000 diverse employees delivered revenue of $5.2 billion in 2021. We are creating a more sustainable world by enabling our customers to optimize water and resource management, and helping communities in more than 150 countries become water-secure. Join us at www.xylem.com.

Forward-Looking Statements

This press release contains “forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Generally, the words “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” "contemplate," "predict," “forecast,” “likely,” “believe,” “target,” “will,” “could,” “would,” “should,” "potential," "may" and similar expressions or their negative, may, but are not necessary to, identify forward-looking statements. By their nature, forward-looking statements address uncertain matters and include any statements that are not historical, such as statements about our strategy, financial plans, outlook, objectives, plans, intentions or goals (including those related to our social, environmental and other sustainability goals); or address possible or future results of operations or financial performance, including statements relating to orders, revenues, operating margins and earnings per share growth.

Although we believe that the expectations reflected in any of our forward-looking statements are reasonable, actual results could differ materially from those projected or assumed in any of our forward-looking statements. Our future financial condition and results of operations, as well as any forward-looking statements, are subject to change and to inherent risks and uncertainties, many of which are beyond our control. Additionally, many of these risks and uncertainties are, and may continue to be, amplified by impacts from the war between Russia and Ukraine, as well as the ongoing coronavirus (“COVID-19”) pandemic and related macroeconomic conditions (including inflation). Important factors that could cause our actual results, performance and achievements, or industry results to differ materially from estimates or projections contained in or implied by our forward-looking statements include, among others, the following: the impact of overall industry and general economic conditions, including industrial, governmental, and public and private sector spending and the strength of the residential and commercial real estate markets, on economic activity and our operations; geopolitical events, including the war between Russia and Ukraine, and regulatory, economic and other risks associated with our global sales and operations, including with respect to domestic content requirements applicable to projects with governmental funding; continued uncertainty around the ongoing COVID-19 pandemic’s magnitude, duration and impacts on our business, operations, growth, and financial condition; actual or potential other epidemics, pandemics or global health crises; availability, shortage or delays in receiving electronic components (in particular, semiconductors), parts, and raw materials from our supply chain; manufacturing and operating cost increases due to macroeconomic conditions, including inflation, supply chain shortages, logistics challenges, tight labor markets, prevailing price changes, tariffs and other factors; demand for our products; disruption, competition or pricing pressures in the markets we serve; cybersecurity incidents or other disruptions of information technology systems on which we rely, or involving our products; disruptions in operations at our facilities or that of third parties upon which we rely; ability to retain and attract senior management and other diverse and key talent, as well as competition for overall talent and labor; difficulty predicting our financial results; defects, security, warranty and liability claims, and recalls with respect to products; availability, regulation or interference with radio spectrum used by certain of our products; uncertainty related to restructuring and realignment actions and related charges and savings; our ability to continue strategic investments for growth; our ability to successfully identify, execute and integrate acquisitions; volatility in served markets or impacts on business and operations due to weather conditions, including the effects of climate change; fluctuations in foreign currency exchange rates; our ability to borrow or refinance our existing indebtedness and uncertainty around the availability of liquidity sufficient to meet our needs; risk of future impairments to goodwill and other intangible assets; failure to comply with, or changes in, laws or regulations, including those pertaining to anti-corruption, data privacy and security, export and import, competition, and the environment and climate change; changes in our effective tax rates or tax expenses; legal, governmental or regulatory claims, investigations or proceedings and associated contingent liabilities; and other factors set forth under “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2021 and in subsequent filings we make with the Securities and Exchange Commission (“SEC”).

Forward-looking and other statements in this press release regarding our environmental and other sustainability plans and goals are not an indication that these statements are necessarily material to investors or are required to be disclosed in our filings with the SEC. In addition, historical, current, and forward-looking social, environmental and sustainability related statements may be based on standards for measuring progress that are still developing, internal controls and processes that continue to evolve, and assumptions that are subject to change in the future. All forward-looking statements made herein are based on information currently available to us as of the date of this press release. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

XYLEM INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED INCOME STATEMENTS (Unaudited)
(in millions, except per share data)

	Three Months					Six Months
For the period ended June 30,	2022		2021			2022		2021
Revenue	$	1,364	$	1,351		$	2,636	$	2,607
Cost of revenue		844		831			1,649		1,597
Gross profit		520		520			987		1,010
Selling, general and administrative expenses		314		304			618		605
Research and development expenses		53		53			105		103
Restructuring and asset impairment charges		7		3			7		9
Operating income		146		160			257		293
Interest expense		12		21			25		42
Other non-operating income (expense), net		2		(3	)		1		(1	)
Gain from sale of business		—		2			1		2
Income before taxes		136		138			234		252
Income tax expense		24		25			40		52
Net income	$	112	$	113		$	194	$	200
Earnings per share:
Basic	$	0.62	$	0.63		$	1.07	$	1.11
Diluted	$	0.62	$	0.62		$	1.07	$	1.10
Weighted average number of shares:
Basic		180.2		180.1			180.2		180.2
Diluted		180.6		181.3			180.8		181.4

XYLEM INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)
(in millions, except per share amounts)

	June 30, 2022			December 31, 2021

ASSETS
Current assets:
Cash and cash equivalents	$	1,113		$	1,349
Receivables, less allowances for discounts, returns and credit losses of $41 and $44 in 2022 and 2021, respectively		1,024			953
Inventories		852			700
Prepaid and other current assets		185			158
Total current assets		3,174			3,160
Property, plant and equipment, net		608			644
Goodwill		2,714			2,792
Other intangible assets, net		975			1,016
Other non-current assets		718			664
Total assets	$	8,189		$	8,276
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	648		$	639
Accrued and other current liabilities		782			752
Short-term borrowings and current maturities of long-term debt		521			—
Total current liabilities		1,951			1,391
Long-term debt		1,879			2,440
Accrued post-retirement benefits		408			438
Deferred income tax liabilities		292			287
Other non-current accrued liabilities		456			494
Total liabilities		4,986			5,050
Stockholders’ equity:
Common Stock – par value $0.01 per share:
Authorized 750.0 shares, issued 195.9 shares and 195.6 shares in 2022 and 2021, respectively		2			2
Capital in excess of par value		2,111			2,089
Retained earnings		2,238			2,154
Treasury stock – at cost 15.8 shares and 15.2 shares in 2022 and 2021, respectively		(708	)		(656	)
Accumulated other comprehensive loss		(448	)		(371	)
Total stockholders’ equity		3,195			3,218
Non-controlling interests		8			8
Total equity		3,203			3,226
Total liabilities and stockholders’ equity	$	8,189		$	8,276

XYLEM INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (in millions)

For the six months ended June 30,	2022			2021
Operating Activities
Net income	$	194		$	200
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation		56			59
Amortization		62			65
Share-based compensation		18			17
Restructuring and asset impairment charges		7			9
Gain from sale of business		(1	)		(2	)
Other, net		6			6
Payments for restructuring		(5	)		(18	)
Changes in assets and liabilities (net of acquisitions):
Changes in receivables		(119	)		(66	)
Changes in inventories		(189	)		(89	)
Changes in accounts payable		40			36
Other, net		(37	)		(11	)
Net Cash – Operating activities		32			206
Investing Activities
Capital expenditures		(95	)		(80	)
Proceeds from sale of business		1			2
Proceeds from the sale of property, plant and equipment		3			—
Cash received from investments		4			—
Cash paid for investments		(7	)		—
Other, net		10			9
Net Cash – Investing activities		(84	)		(69	)
Financing Activities
Repurchase of common stock		(52	)		(68	)
Proceeds from exercise of employee stock options		3			9
Dividends paid		(110	)		(102	)
Other, net		1			(1	)
Net Cash – Financing activities		(158	)		(162	)
Effect of exchange rate changes on cash		(26	)		(10	)
Net change in cash and cash equivalents		(236	)		(35	)
Cash and cash equivalents at beginning of year		1,349			1,875
Cash and cash equivalents at end of period	$	1,113		$	1,840
Supplemental disclosure of cash flow information:
Cash paid during the period for:
Interest	$	40		$	58
Income taxes (net of refunds received)	$	42		$	60

Xylem Inc. Non-GAAP Measures

Management reviews key performance indicators including revenue, gross margins, segment operating income and margins, orders growth, working capital and backlog, among others. In addition, we consider certain non-GAAP (or "adjusted") measures to be useful to management and investors evaluating our operating performance for the periods presented, and to provide a tool for evaluating our ongoing operations, liquidity and management of assets. This information can assist investors in assessing our financial performance and measures our ability to generate capital for deployment among competing strategic alternatives and initiatives, including but not limited to, dividends, acquisitions, share repurchases and debt repayment. Excluding revenue, Xylem provides guidance only on a non-GAAP basis due to the inherent difficulty in forecasting certain amounts that would be included in GAAP earnings, such as discrete tax items, without unreasonable effort. These adjusted metrics are consistent with how management views our business and are used to make financial, operating and planning decisions. These metrics, however, are not measures of financial performance under GAAP and should not be considered a substitute for revenue, operating income, net income, earnings per share (basic and diluted) or net cash from operating activities as determined in accordance with GAAP. We consider the following items to represent the non-GAAP measures we consider to be key performance indicators, as well as the related reconciling items to the most directly comparable measure calculated and presented in accordance with GAAP. The non-GAAP measures may not be comparable to similarly titled measures reported by other companies.

“Organic revenue" and "Organic orders” defined as revenue and orders, respectively, excluding the impact of fluctuations in foreign currency translation and contributions from acquisitions and divestitures. Divestitures include sales or discontinuance of insignificant portions of our business that did not meet the criteria for classification as a discontinued operation. The period-over-period change resulting from foreign currency translation impacts is determined by translating current period and prior period activity using the same currency conversion rate.

“Constant currency” defined as financial results adjusted for foreign currency translation impacts by translating current period and prior period activity using the same currency conversion rate. This approach is used for countries whose functional currency is not the U.S. dollar.

“EBITDA” defined as earnings before interest, taxes, depreciation and amortization expense. “Adjusted EBITDA” and "Adjusted Segment EBITDA" reflect the adjustments to EBITDA and segment EBITDA, respectively, to exclude share-based compensation charges, restructuring and realignment costs, gain or loss from sale of businesses and special charges.

"Adjusted EBITDA Margin" and "Adjusted Segment EBITDA Margin" defined as adjusted EBITDA and adjusted segment EBITDA divided by total revenue and segment revenue, respectively.

"Adjusted Operating Income", "Adjusted Segment Operating Income", "Adjusted Net Income" and “Adjusted EPS” defined as operating income, segment operating income, net income and earnings per share, adjusted to exclude restructuring and realignment costs, gain or loss from sale of businesses, special charges and tax-related special items, as applicable.

"Adjusted Operating Margin" and "Adjusted Segment Operating Margin" defined as adjusted operating income and adjusted segment operating income divided by total revenue and segment revenue, respectively.

“Free Cash Flow” defined as net cash from operating activities, as reported in the Statement of Cash Flows, less capital expenditures, and "Free Cash Flow Conversion" defined as Free Cash Flows divided by net income, excluding the gain on sale of businesses, non-cash impairment charges and significant deferred tax items. Our definitions of "free cash flow" and "free cash flow conversion" do not consider certain non-discretionary cash payments, such as debt.

“Realignment costs” defined as costs not included in restructuring costs that are incurred as part of actions taken to reposition our business, including items such as professional fees, severance, relocation, travel, facility set-up and other costs.

“Special charges" defined as costs incurred by the Company, such as acquisition and integration related costs, non-cash impairment charges and both operating and non-operating adjustments for costs related to the UK pension plan buyout.

“Tax-related special items" defined as tax items, such as tax return versus tax provision adjustments, tax exam impacts, tax law change impacts, excess tax benefits/losses and other discrete tax adjustments.

Xylem Inc. Non-GAAP Reconciliation
Reported vs. Organic & Constant Currency Orders ($ Millions)

	(As Reported - GAAP)				(As Adjusted - Organic)				Constant Currency
		(A)	(B)		(C)	(D)	(E) = B+C+D	(F) = E/A	(G) = (E - C) / A
			Change	% Change	Acquisitions / Divestitures		Change	% Change
	Orders	Orders	2022 v. 2021	2022 v. 2021	Acquisitions / Divestitures	FX Impact	Adj. 2022 v. 2021	Adj. 2022 v. 2021
	2022	2021
Six Months Ended June 30
Xylem Inc.	3,399	3,198	201	6%	11	107	319	10%	10%
Water Infrastructure	1,391	1,250	141	11%	-	66	207	17%	17%
Applied Water	985	963	22	2%	-	25	47	5%	5%
Measurement & Control Solutions	1,023	985	38	4%	11	16	65	7%	5%

Quarter Ended June 30
Xylem Inc.	1,684	1,660	24	1%	5	67	96	6%	5%
Water Infrastructure	731	639	92	14%	-	42	134	21%	21%
Applied Water	480	486	(6)	(1%)	-	15	9	2%	2%
Measurement & Control Solutions	473	535	(62)	(12%)	5	10	(47)	(9%)	(10%)

Quarter Ended March 31
Xylem Inc.	1,715	1,538	177	12%	6	40	223	14%	14%
Water Infrastructure	660	611	49	8%	-	24	73	12%	12%
Applied Water	505	477	28	6%	-	10	38	8%	8%
Measurement & Control Solutions	550	450	100	22%	6	6	112	25%	24%

Xylem Inc. Non-GAAP Reconciliation
Reported vs. Organic & Constant Currency Revenue ($ Millions)

	(As Reported - GAAP)				(As Adjusted - Organic)				Constant Currency
		(A)	(B)		(C)	(D)	(E) = B+C+D	(F) = E/A	(G) = (E - C) / A
			Change	% Change	Acquisitions / Divestitures		Change	% Change
	Revenue	Revenue	2022 v. 2021	2022 v. 2021	Acquisitions / Divestitures	FX Impact	Adj. 2022 v. 2021	Adj. 2022 v. 2021
	2022	2021
Six Months Ended June 30
Xylem Inc.	2,636	2,607	29	1%	5	93	127	5%	5%
Water Infrastructure	1,122	1,078	44	4%	-	53	97	9%	9%
Applied Water	854	807	47	6%	-	23	70	9%	9%
Measurement & Control Solutions	660	722	(62)	(9%)	5	17	(40)	(6%)	(6%)

Quarter Ended June 30
Xylem Inc.	1,364	1,351	13	1%	3	60	76	6%	5%
Water Infrastructure	589	569	20	4%	-	34	54	9%	9%
Applied Water	429	414	15	4%	-	15	30	7%	7%
Measurement & Control Solutions	346	368	(22)	(6%)	3	11	(8)	(2%)	(3%)

Quarter Ended March 31
Xylem Inc.	1,272	1,256	16	1%	2	33	51	4%	4%
Water Infrastructure	533	509	24	5%	-	19	43	8%	8%
Applied Water	425	393	32	8%	-	8	40	10%	10%
Measurement & Control Solutions	314	354	(40)	(11%)	2	6	(32)	(9%)	(10%)

Xylem Inc. Non-GAAP Reconciliation
Adjusted Operating Income ($ Millions)


		Q1				Q2				YTD
		2022		2021		2022		2021		2022		2021
	Total Revenue
	• Total Xylem	1,272		1,256		1,364		1,351		2,636		2,607
	• Water Infrastructure	533		509		589		569		1,122		1,078
	• Applied Water	425		393		429		414		854		807
	• Measurement & Control Solutions	314		354		346		368		660		722

	Operating Income (Loss)
	• Total Xylem	111		133		146		160		257		293
	• Water Infrastructure	74		71		108		93		182		164
	• Applied Water	59		66		61		64		120		130
	• Measurement & Control Solutions	(10	)	9		(5	)	13		(15	)	22
	• Total Segments	123		146		164		170		287		316

	Operating Margin
	• Total Xylem	8.7	%	10.6	%	10.7	%	11.8	%	9.7	%	11.2	%
	• Water Infrastructure	13.9	%	13.9	%	18.3	%	16.3	%	16.2	%	15.2	%
	• Applied Water	13.9	%	16.8	%	14.2	%	15.5	%	14.1	%	16.1	%
	• Measurement & Control Solutions	(3.2	%)	2.5	%	(1.4	%)	3.5	%	(2.3	%)	3.0	%
	• Total Segments	9.7	%	11.6	%	12.0	%	12.6	%	10.9	%	12.1	%

	Special Charges
	• Total Xylem	1		2		1		-		2		2
	• Water Infrastructure	-		-				-		-		-
	• Applied Water	-		1				-		-		1
	• Measurement & Control Solutions	-		-		1		-		1		-
	• Total Segments	-		1		1		-		1		1

	Restructuring & Realignment Costs
	• Total Xylem	4		8		8		6		12		14
	• Water Infrastructure	1		5		3		4		4		9
	• Applied Water	1		1		2		2		3		3
	• Measurement & Control Solutions	2		2		3		-		5		2
	• Total Segments	4		8		8		6		12		14

	Adjusted Operating Income (Loss)
	• Total Xylem	116		143		155		166		271		309
	• Water Infrastructure	75		76		111		97		186		173
	• Applied Water	60		68		63		66		123		134
	• Measurement & Control Solutions	(8	)	11		(1	)	13		(9	)	24
	• Total Segments	127		155		173		176		300		331

	Adjusted Operating Margin
	• Total Xylem	9.1	%	11.4	%	11.4	%	12.3	%	10.3	%	11.9	%
	• Water Infrastructure	14.1	%	14.9	%	18.8	%	17.0	%	16.6	%	16.0	%
	• Applied Water	14.1	%	17.3	%	14.7	%	15.9	%	14.4	%	16.6	%
	• Measurement & Control Solutions	(2.5	%)	3.1	%	(0.3	%)	3.5	%	(1.4	%)	3.3	%
	• Total Segments	10.0	%	12.3	%	12.7	%	13.0	%	11.4	%	12.7	%

Xylem Inc. Non-GAAP Reconciliation
Adjusted Diluted EPS
($ Millions, except per share amounts)

		Q2 2022										Q2 2021
		As Reported			Adjustments				Adjusted			As Reported			Adjustments				Adjusted
	Total Revenue		1,364			-				1,364			1,351			-				1,351
	Operating Income		146			9		a		155			160			6		a		166
	Operating Margin		10.7	%						11.4	%		11.8	%						12.3	%
	Interest Expense		(12	)		-				(12	)		(21	)		-				(21	)
	Other Non-Operating Income (Expense)		2			2		b		4			(3	)		3		b		-
	Gain/(Loss) From Sale of Business		-			-				-			2			(2	)			-
	Income before Taxes		136			11				147			138			7				145
	Provision for Income Taxes		(24	)		(3	)	c		(27	)		(25	)		(1	)	c		(26	)
	Net Income Attributable to Xylem		112			8				120			113			6				119
	Diluted Shares		180.6							180.6			181.3							181.3
	Diluted EPS	$	0.62		$	0.04			$	0.66		$	0.62		$	0.04			$	0.66

	Year-over-year currency translation impact on current year diluted EPS	$	(0.08	)	$	-			$	(0.08	)
	Diluted EPS at Constant Currency	$	0.70		$	0.04			$	0.74



		Q2 YTD 2022										Q2 YTD 2021
		As Reported			Adjustments				Adjusted			As Reported			Adjustments				Adjusted
	Total Revenue		2,636			-				2,636			2,607			-				2,607
	Operating Income		257			14		a		271			293			16		a		309
	Operating Margin		9.7	%						10.3	%		11.2	%						11.9	%
	Interest Expense		(25	)		-				(25	)		(42	)		-				(42	)
	Other Non-Operating Income (Expense)		1			3		b		4			(1	)		4		b		3
	Gain/(Loss) From Sale of Business		1			(1	)			-			2			(2	)			-
	Income before Taxes		234			16				250			252			18				270
	Provision for Income Taxes		(40	)		(6	)	c		(46	)		(52	)		3		c		(49	)
	Net Income Attributable to Xylem		194			10				204			200			21				221
	Diluted Shares		180.8							180.8			181.4							181.4
	Diluted EPS	$	1.07		$	0.06			$	1.13		$	1.10		$	0.13			$	1.23

	Year-over-year currency translation impact on current year diluted EPS	$	(0.12	)	$	(0.00	)		$	(0.12	)
	Diluted EPS at Constant Currency	$	1.19		$	0.06			$	1.25


a	Quarter-to-date: Restructuring & realignment costs of $8 million in 2022 and $6 million in 2021, as well as special charges of $1 million in 2022 (related to intangible asset impairment).
	Year-to-date: Restructuring & realignment costs of $12 million in 2022 and $14 million in 2021, as well as special charges of $2 million ($1 million of intangible asset impairment charges and $1 million for pension costs related to the UK pension plan) in both 2022 and 2021.
b	Quarter-to-date: Special non-operating charges consist of $2 million in 2022 and $3 million in 2021 for costs related to the UK pension plan that is going to be part of a buyout.
	Year-to-date: Special non-operating charges consist of $3 million in 2022 and $4 million in 2021 for costs related to the UK pension plan that is going to be part of a buyout.
c	Quarter-to-date: Net tax impact on restructuring & realignment costs of $2 million in 2022 and $1 million in 2021; $1 million net tax impact on special charges in 2021; and $1 million of negative impact from tax related special benefits to GAAP tax in 2022 and $1 million of positive impact from tax related special charges to GAAP tax in 2021.
	Year-to-date: Net tax impact on restructuring & realignment costs of $3 million in both 2022 and 2021; $1 million net tax impact on special charges in 2022 and 2021; and $2 million of negative impact from tax related special benefits to GAAP tax in 2022 and $7 million of positive impact from tax related special charges to GAAP tax in 2021.

Xylem Inc. Non-GAAP Reconciliation
Net Cash - Operating Activities vs. Free Cash Flow ($ Millions)

	Q1						Q2						Year-to-Date

	2022			2021			2022			2021			2022			2021

Net Cash - Operating Activities	$	(81	)	$	(26	)	$	113		$	232		$	32		$	206

Capital Expenditures - PP&E		(31	)		(22	)		(30	)		(25	)		(61	)		(47	)
Capital Expenditures - Software		(18	)		(17	)		(16	)		(16	)		(34	)		(33	)
Capital Expenditures		(49	)		(39	)		(46	)		(41	)		(95	)		(80	)

Free Cash Flow	$	(130	)	$	(65	)	$	67		$	191		$	(63	)	$	126

Free Cash Flow	$	(130	)	$	(65	)	$	67		$	191		$	(63	)	$	126

Net Income		82			87			112			113			194			200

Gain/(Loss) from sale of business		1			-			-			2			1			2

Restructuring & Realignment Charges - non-cash impairment		-			(1	)		-			-			-			(1	)

Special Charges - non-cash impairment		-			(1	)		(1	)		-			(1	)		(1	)

Net Income, excluding gain on sale of businesses, non-cash impairment charges and significant deferred tax items	$	81		$	89		$	113		$	111		$	194		$	200

Operating Cash Flow Conversion		(99	%)		(30	%)		101	%		205	%		16	%		103	%

Free Cash Flow Conversion		(160	%)		(73	%)		59	%		172	%		(32	%)		63	%

Xylem Inc. Non-GAAP Reconciliation
EBITDA and Adjusted EBITDA by Quarter ($ Millions)


2022
	Q1		Q2		Q3		Q4		Total

Net Income	82		112						194
Income Tax Expense	16		24						40
Interest Expense (Income), net	11		10						21
Depreciation	28		28						56
Amortization	30		32						62
EBITDA	167		206						373
Share-based Compensation	9		9						18
Restructuring & Realignment	4		8						12
Loss/(Gain) from sale of business	(1	)	-						(1	)
Special Charges	2		3						5
Adjusted EBITDA	181		226						407
Revenue	1,272		1,364						2,636
Adjusted EBITDA Margin	14.2	%	16.6	%					15.4	%

2021
	Q1		Q2		Q3		Q4		Total

Net Income	87		113		114		113		427
Income Tax Expense	27		25		19		13		84
Interest Expense (Income), net	19		19		20		11		69
Depreciation	30		29		31		28		118
Amortization	32		33		31		31		127
EBITDA	195		219		215		196		825
Share-based Compensation	9		8		8		8		33
Restructuring & Realignment	8		6		2		6		22
Loss/(Gain) from sale of business	-		(2	)	-		-		(2	)
Special Charges	3		3		2		4		12
Adjusted EBITDA	215		234		227		214		890
Revenue	1,256		1,351		1,265		1,323		5,195
Adjusted EBITDA Margin	17.1	%	17.3	%	17.9	%	16.2	%	17.1	%

Xylem Inc. Non-GAAP Reconciliation
EBITDA and Adjusted EBITDA by Quarter ($ Millions)
Water Infrastructure

2022
	Q1		Q2		Q3		Q4		Total

Pre-Tax Income	71		109						180
Income Tax Expense
Interest Expense (Income), net	(1	)	-						(1	)
Depreciation	11		11						22
Amortization	2		3						5
EBITDA	83		123						206
Share-based Compensation	1		-						1
Restructuring & Realignment	1		3						4
Loss/(Gain) from sale of business			-						-
Special Charges			-						-
Adjusted EBITDA	85		126						211
Revenue	533		589						1,122
Adjusted EBITDA Margin	15.9	%	21.4	%					18.8	%

2021
	Q1		Q2		Q3		Q4		Total

Pre-Tax Income	70		92		102		121		385
Income Tax Expense									-
Interest Expense (Income), net	(1	)	(1	)	-		(1	)	(3	)
Depreciation	11		11		11		10		43
Amortization	2		2		1		3		8
EBITDA	82		104		114		133		433
Share-based Compensation	1		-		1		-		2
Restructuring & Realignment	5		4		1		2		12
Loss/(Gain) from sale of business									-
Special Charges									-
Adjusted EBITDA	88		108		116		135		447
Revenue	509		569		547		622		2,247
Adjusted EBITDA Margin	17.3	%	19.0	%	21.2	%	21.7	%	19.9	%

Xylem Inc. Non-GAAP Reconciliation
EBITDA and Adjusted EBITDA by Quarter ($ Millions)
Applied Water

2022
	Q1		Q2		Q3		Q4		Total

Pre-Tax Income	58		61						119
Income Tax Expense
Interest Expense (Income), net	-		-						-
Depreciation	5		4						9
Amortization	-		1						1
EBITDA	63		66						129
Share-based Compensation	1		1						2
Restructuring & Realignment	1		2						3
Loss/(Gain) from sale of business	-		-						-
Special Charges	-		-						-
Adjusted EBITDA	65		69						134
Revenue	425		429						854
Adjusted EBITDA Margin	15.3	%	16.1	%					15.7	%

2021
	Q1		Q2		Q3		Q4		Total

Pre-Tax Income	66		65		60		48		239
Income Tax Expense									-
Interest Expense (Income), net	-		-		-		-		-
Depreciation	5		5		5		5		20
Amortization	1		1		-		-		2
EBITDA	72		71		65		53		261
Share-based Compensation	1		1		1		1		4
Restructuring & Realignment	1		2		2		2		7
Loss/(Gain) from sale of business	-		(2	)	-		-		(2	)
Special Charges	1		-		-		-		1
Adjusted EBITDA	75		72		68		56		271
Revenue	393		414		400		406		1,613
Adjusted EBITDA Margin	19.1	%	17.4	%	17.0	%	13.8	%	16.8	%

Xylem Inc. Non-GAAP Reconciliation
EBITDA and Adjusted EBITDA by Quarter ($ Millions)
Measurement & Control Solutions

2022
	Q1		Q2		Q3		Q4		Total

Pre-Tax Income	(9	)	(6	)					(15	)
Income Tax Expense
Interest Expense (Income), net	-		-						-
Depreciation	9		8						17
Amortization	25		26						51
EBITDA	25		28						53
Share-based Compensation	1		2						3
Restructuring & Realignment	2		3						5
Loss/(Gain) from sale of business	(1	)	-						(1	)
Special Charges			1						1
Adjusted EBITDA	27		34						61
Revenue	314		346						660
Adjusted EBITDA Margin	8.6	%	9.8	%					9.2	%

2021
	Q1		Q2		Q3		Q4		Total

Pre-Tax Income	8		12		7		(17	)	10
Income Tax Expense									-
Interest Expense (Income), net	-		-		-		-		-
Depreciation	9		10		11		8		38
Amortization	27		27		27		26		107
EBITDA	44		49		45		17		155
Share-based Compensation	1		2		1		2		6
Restructuring & Realignment	2		-		(1	)	2		3
Loss/(Gain) from sale of business									-
Special Charges									-
Adjusted EBITDA	47		51		45		21		164
Revenue	354		368		318		295		1,335
Adjusted EBITDA Margin	13.3	%	13.9	%	14.2	%	7.1	%	12.3	%

View source version on businesswire.com: https://www.businesswire.com/news/home/20220801005731/en/

Contacts

Media

Houston Spencer +1 (914) 323-5723

houston.spencer@xylem.com

Investors

Andrea van der Berg +1 (202) 869-9151

andrea.vanderberg@xylem.com